INDOCO REMEDIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 310.2 INR | +3.99% |
|
-1.48% | -21.51% |
| 05-22 | Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules | MT |
| 05-21 | Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 329M | - | - | ||||
| 750B | ||||||
| 606B | ||||||
| 356B | ||||||
| 326B | ||||||
| 286B |
